Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Fenaux

Showing results (71-80 of 432) with videos related to

Pageof 44
Sort By:
Blood|March 16, 2002
p16(INK4a) immunocytochemical analysis is an independent prognostic factor in childhood acute lymphoblastic leukemiaJean Hughes Dalle, Martine Fournier, Brigitte Nelken, et al.
British Journal of Haematology|August 30, 2002
Acquired trisomy 21 and distinct clonal evolution in acute megakaryoblastic leukaemia in young monozygotic twinsBatia Stark, Marta Jeison, Claude Preudhomme, et al.
Apoptosis : an International Journal on Programmed Cell Death|January 25, 2007
Differentiating megakaryocytes in myelodysplastic syndromes succumb to mitochondrial derangement without caspase activationThorsten Braun, Gabrielle Carvalho, Jennifer Grosjean, et al.
Cell Cycle (Georgetown, Tex.)|August 27, 2013
EGFR inhibitors exacerbate differentiation and cell cycle arrest induced by retinoic acid and vitamin D3 in acute myeloid leukemia cellsElodie Lainey, Alice Wolfromm, Abdul Qader Sukkurwala, et al.
Leukemia Research|July 9, 2010
Practical use of azacitidine in higher-risk myelodysplastic syndromes: an expert panel opinionPierre Fenaux, David Bowen, Norbert Gattermann, et al.
BMC Cancer|September 10, 2022
Machine learning-based improvement of MDS-CBC score brings platelets into the limelight to optimize smear review in the hematology laboratoryJaja Zhu, Pierre Lemaire, Stéphanie Mathis, et al.
Leukemia Research|September 15, 2018
Association between health literacy, communication and psychological distress among myelodysplastic syndromes patientsYoussoufa M Ousseine, Phyllis N Butow, Pierre Fenaux, et al.
Haematologica|November 27, 2010
Cytogenetic follow-up by karyotyping and fluorescence in situ hybridization: implications for monitoring patients with myelodysplastic syndrome and deletion 5q treated with lenalidomideGudrun Göhring, Aristoteles Giagounidis, Guntram Büsche, et al.
Rheumatology (Oxford, England)|November 9, 2020
Low dose IL-2 in patients with steroid-dependent dysimmune manifestations associated with myelodysplastic syndromes: a three-case reportMarion Corfmat, Christophe Willekens, Julien Vinit, et al.
European Journal of Haematology|November 22, 2007
Synchronous FIP1L1-PDGFRA-positive chronic eosinophilic leukemia and T-cell lymphoblastic lymphoma: a bilineal clonal malignancyMathieu Capovilla, Jean-Michel Cayuela, Chrystèle Bilhou-Nabera, et al.
Pageof 44

Showing results (71-80 of 432) with videos related to

Sort By:
Pageof 44
Blood|March 16, 2002
p16(INK4a) immunocytochemical analysis is an independent prognostic factor in childhood acute lymphoblastic leukemiaJean Hughes Dalle, Martine Fournier, Brigitte Nelken, et al.
British Journal of Haematology|August 30, 2002
Acquired trisomy 21 and distinct clonal evolution in acute megakaryoblastic leukaemia in young monozygotic twinsBatia Stark, Marta Jeison, Claude Preudhomme, et al.
Apoptosis : an International Journal on Programmed Cell Death|January 25, 2007
Differentiating megakaryocytes in myelodysplastic syndromes succumb to mitochondrial derangement without caspase activationThorsten Braun, Gabrielle Carvalho, Jennifer Grosjean, et al.
Cell Cycle (Georgetown, Tex.)|August 27, 2013
EGFR inhibitors exacerbate differentiation and cell cycle arrest induced by retinoic acid and vitamin D3 in acute myeloid leukemia cellsElodie Lainey, Alice Wolfromm, Abdul Qader Sukkurwala, et al.
Leukemia Research|July 9, 2010
Practical use of azacitidine in higher-risk myelodysplastic syndromes: an expert panel opinionPierre Fenaux, David Bowen, Norbert Gattermann, et al.
BMC Cancer|September 10, 2022
Machine learning-based improvement of MDS-CBC score brings platelets into the limelight to optimize smear review in the hematology laboratoryJaja Zhu, Pierre Lemaire, Stéphanie Mathis, et al.
Leukemia Research|September 15, 2018
Association between health literacy, communication and psychological distress among myelodysplastic syndromes patientsYoussoufa M Ousseine, Phyllis N Butow, Pierre Fenaux, et al.
Haematologica|November 27, 2010
Cytogenetic follow-up by karyotyping and fluorescence in situ hybridization: implications for monitoring patients with myelodysplastic syndrome and deletion 5q treated with lenalidomideGudrun Göhring, Aristoteles Giagounidis, Guntram Büsche, et al.
Rheumatology (Oxford, England)|November 9, 2020
Low dose IL-2 in patients with steroid-dependent dysimmune manifestations associated with myelodysplastic syndromes: a three-case reportMarion Corfmat, Christophe Willekens, Julien Vinit, et al.
European Journal of Haematology|November 22, 2007
Synchronous FIP1L1-PDGFRA-positive chronic eosinophilic leukemia and T-cell lymphoblastic lymphoma: a bilineal clonal malignancyMathieu Capovilla, Jean-Michel Cayuela, Chrystèle Bilhou-Nabera, et al.
Pageof 44